Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · IEX Real-Time Price · USD
14.53
+0.57 (4.08%)
At close: Apr 26, 2024, 4:00 PM
14.63
+0.10 (0.69%)
After-hours: Apr 26, 2024, 7:49 PM EDT
Scholar Rock Holding Employees
Scholar Rock Holding had 150 employees on December 31, 2023. The number of employees increased by 36 or 31.58% compared to the previous year.
Employees
150
Change (1Y)
36
Growth (1Y)
31.58%
Revenue / Employee
n/a
Profits / Employee
-$1,105,260
Market Cap
1.16B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 150 | 36 | 31.58% |
Dec 31, 2022 | 114 | -31 | -21.38% |
Dec 31, 2021 | 145 | 26 | 21.85% |
Dec 31, 2020 | 119 | 26 | 27.96% |
Dec 31, 2019 | 93 | 28 | 43.08% |
Dec 31, 2018 | 65 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
AtriCure | 1,050 |
Vir Biotechnology | 587 |
AbCellera Biologics | 586 |
Deciphera Pharmaceuticals | 355 |
Xencor | 280 |
Mirum Pharmaceuticals | 264 |
Collegium Pharmaceutical | 197 |
Belite Bio | 20 |
SRRK News
- 14 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress - Business Wire
- 2 months ago - Scholar Rock to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer - Business Wire
- 2 months ago - Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management - Business Wire
- 3 months ago - Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia - Business Wire
- 3 months ago - Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity - Business Wire
- 4 months ago - Scholar Rock Provides Corporate Update and Highlights Priorities for 2024 - Business Wire